Prognostic Factors in Non-Hodgkin’s Lymphoma Patients Treated by Autologous Stem Cell Transplantation: A Single Center Experience
2
조회
0
다운로드
2
인용
0
참고문헌
초록
Abstract
Purpose: Autologous stem cell transplantation (ASCT) is increasingly used in patients with non-Hodgkin’s lymphoma (NHL). Various clinical parameters-were evaluated to obtain significant predictors of the outcome following ASCT in patients with NHL Materials and Methods: Between April 1994 and December 2003, ASCT was performed on 80 patients with NHL at the Asan Medical Center. Results: Patients had various histological subtypes and disease status. The two year progression free survival (PFS) and overall survival for all patients were 34 and 31%, respectively. A univariate analysis showed the performance status, stage, modified extranodal involvement category, International Prognostic Index (IPI) at mobilization, disease status at mobilization, and history of radiation prior to mobilization as significant predictors of the outcome following ASCT. Four risk groups, with different 2 year PFS, were identified by the age adjusted IPI at mobilization (mAAIPI): low risk 44%; low intermediate risk 40%; high intermediate risk 19%; and high risk 0% (p=.0003). A multivariate analysis revealed 3 significant factors for the PFS: disease status, prior RT and mAAIPI. Conclusion: The mAAIPI was found to be an independent predictor of the outcome of NHL patients undergoing ASCT. This powerful prognostic tool should be used to evaluate potential candidates for ASCT.
참고문헌 (12)
- "High dose therapy in lymphomas:areview of the current status of allogeneic and autologous stemcell transplantation in Hodgkin's disease and non Hodgkin'slymphoma", 6, pp.247~56 (2001)
- "Successful engraftment of cryopreserved autologousbone marrow in patients with malignant lymphoma", 52, pp.85~95 (1978)
- "High dose therapy and autologous bonemarrow transplantation after failure of conventional chemotherapyin adults with intermediate grade or high grade nonHodgkin's lymphoma", 316, pp.1493~8 (1987)
- "High dose chemotherapy and autologoushematopoietic stem cell transplantation for aggressive nonHodgkin's lymphoma", 11, pp.1846~51 (1993)
- "Autologous marrow transplantation formalignant lymphoma:a report of 101 cases from Seattle", 8, pp.638~47 (1990)
- "Autotransplantation for relapsed or refractorynon Hodgkin’s lymphoma (NHL) long term follow upand analysis of prognostic factors.", 19, pp.883~90 (1997)
- "The treatment of progressive non Hodgkin'slymphoma with intensive chemoradiotherapy and autologousmarrow transplantation", 75, pp.831~8 (1990)
- "The International Non Hodgkin's Lymphoma PrognosticFactors Project", 329, pp.987~94 (1993)
- "International prognosticindex for aggressive non hodgkin's lymphoma is valid for allmalignancy grades", 86, pp.1460~3 (1995)
- "The international prognostic index correlates to survivalin patients with aggressive lymphoma in relapse:analysisof the PARMA trial", 92, pp.3562~8 (1998)
- "The international prognostic indexpredicts for outcome following autologous stem cell transplantationin patients with relapsed and primary refractory intermediategrade lymphoma", 23, pp.561~7 (1999)
- "Patients with high risk aggressive lymphomatreated with frontline intensive chemotherapy and autograftingevidence of marked differences in outcome between patientswith age adjusted International Prognostic Index scores 2 and", Cuttica A